Advertisement

Topics

Cambridge Antibody Technology Group plc Company Profile

09:41 EST 22nd November 2017 | BioPortfolio

The foundation of CAT's business is its unique antibody technologies, which it continues to develop and exploit. Based on this, CAT has established a position as a world leader, exploiting the characteristics of antibodies both to discover and validate new disease targets and to develop human monoclonal antibodies as new treatments for disease.

Location

The Science Park
Melbourn
Cambridgeshire
SG8 6JJ
United Kingdom

Contact

Phone: +44 (0) 1763 263 233
Fax: +44 (0) 1763 263 413
Email: info@cambridgeantibody.com


News Articles [1379 Associated News Articles listed on BioPortfolio]

#jobs #lifescience Paramount Recruitment: Protein Scientist – Antibody – Cambridge

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Paramount Recruitment: Protein Scientist – Antibody – Cambridge ....

This Antibody Eliminates Rejection of Bone Marrow Transplants in Mice

Kymab has published positive results in Science Translational Medicine for a new antibody with the potential to prevent rejection in bone marrow transplants. Kymab is an antibody company based in Camb...

Qkine signs deal to drive stem cell and regenerative medicine research

(University of Cambridge) Cambridge Enterprise, the commercialization arm of the University of Cambridge, and specialist growth factor manufacturer Qkine Ltd have signed a key licensing deal for Activ...

#jobs #lifescience MedImmune: Antibody Discovery Scientist – Hybridoma (Sci I)

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: MedImmune: Antibody Discovery Scientist – Hybridoma (Sci I) . Negotiabl...

Cambridge Enterprise: How Apollo Therapeutics is driving forward therapeutic innovation.

Iain Thomas, Head of Life Sciences at Cambridge University’s technology transfer arm, discusses the recent launch of Apollo Therapeutics, an ambitious collaboration between AstraZeneca, GlaxoSmithK...

Morphotek To Present Its Proprietary RESPECT™ Antibody Drug Conjugate (ADC) Technology At The ...

RESPECT is a site-specific conjugation technology that targets select amino acid residues as a way of producing investigational homogeneous ADCs with defined drug-to-antibody ratios.  The Read mo...

‘Double Decker’ Antibody Technology Fights Cancer

NewsA new class of antibody-drug conjugates use a technology that ties antibodies and a drug together to produce highly potent pharmaceuticals for cancer therapy.

#jobs #lifescience MedImmune: Intern – Antibody Discovery and Protein Engineering (FTC)

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: MedImmune: Intern – Antibody Discovery and Protein Engineering (FTC) . ...

PubMed Articles [3900 Associated PubMed Articles listed on BioPortfolio]

Antibody 27F3 Broadly Targets Influenza A Group 1 and 2 Hemagglutinins through a Further Variation in VH1-69 Antibody Orientation on the HA Stem.

Antibodies that target both group 1 and group 2 influenza A viruses are valuable for therapeutic and vaccine development, but only a few have been reported to date. Here, we describe a new VH1-69 anti...

Anti-Dll4 Antibody Inhibits the Differentiation of Th17 Cells in Asthmatic Mice.

T helper 17 (Th17) cells play an important role in allergic asthma, and the Notch ligand Delta-like ligand (Dll)4 has been reported to direct the differentiation of Th17 cells. In this study, experime...

A Case of a Newborn With Blocked RhD Antigen and HDFN.

A group O RhD-negative pregnant patient with anti-D antibody at titer 1:2048 delivered a baby boy by cesarean section at 38 + 6 weeks gestational age. The neonate typed as group O, but D antigen was a...

Effects of Gelatin Hydrogel Containing Anti-Transforming Growth Factor-β Antibody in a Canine Filtration Surgery Model.

In this present study, we investigated the effect of a controlled release of anti-transforming growth factor β (TGF-β) antibody on intraocular pressure (IOP), bleb formation, and conjunctival scarri...

The effect of thyroid autoantibody positivity on the functions of internal ear.

The objective of the study is to investigate if any significant difference exists in hearing thresholds and tympanometric examination results among patients whose thyroid antibody positivity was detec...

Clinical Trials [5833 Associated Clinical Trials listed on BioPortfolio]

Feasibility Study Identifying Antibody Levels Associated With Reduced Risk of Invasive Group B Streptococcus Disease in Young Infants.

Feasibility phase for a study to evaluate antibody levels against Group B Streptococcus in mothers and their infants at delivery to establish antibody levels associated with reductions in ...

A Study to Assess the Persistence of a GBS Antibody in Women Previously Immunized With a GBS Vaccine

This study looks at the body's immune responses to a GBS vaccine 2 years after the orginal vaccine(s) were given in the V98P1 study. Blood will be drawn and evaluated for GBS antibody lev...

Artificial Shrinkage of Fresh Blastocysts

The aim of the study is to determine if collapsing an embryo (or making it fold compactly by taking away its fluid) before the transfer in the uterine cavity improves pregnancy rates in as...

User Evaluation of the Peristomal Skin Condition in Ostomates Using ConvaTec Moldable Technology™

The primary aim of this study is to demonstrate the maintenance of healthy peri-stomal skin over a two month period in subjects who use ConvaTec Moldable Technology™ Skin Barriers as par...

Immune Response of Patients With Chronic, Staphylococcus Aureus-infected Wounds

The primary objective of this study is to detect differences in anti-S. aureus antibody assays (IgM, IgA, IgG and its subclasses) between (1) a group of patients with bacteremia due to a c...

Companies [3059 Associated Companies listed on BioPortfolio]

Cambridge Antibody Technology

Cambridge Antibody Technology (CAT) is a biopharmaceutical company committed to developing human monoclonal antibody therapeutics to bring improvements to seriously ill patients' lives.CAT has strong ...

Cambridge Antibody Technology Group plc

The foundation of CAT's business is its unique antibody technologies, which it continues to develop and exploit. Based on this, CAT has established a position as a world leader, exploiting the charact...

Domantis Inc

Domantis Limited was launched in December 2000 by Sir Gregory Winter and Dr Ian Tomlinson of the MRC–LMB with the backing of the MRC and MVM Limited to commercialise Domain Antibody products. To dat...

Granta Park Ltd

Granta Park has established itself as the leading research park in the Cambridge sub-region. Concentrating on the life sciences it has attracted many of the foremost businesses in the field, including...

The Cambridge Group

The Cambridge Group (http://www.thecambridgegroup.com) is a strategy consulting firm focused on the development of growth strategies for Fortune 500 companies. For over 30 years, The Cambridge Gr...

More Information about "Cambridge Antibody Technology Group plc" on BioPortfolio

We have published hundreds of Cambridge Antibody Technology Group plc news stories on BioPortfolio along with dozens of Cambridge Antibody Technology Group plc Clinical Trials and PubMed Articles about Cambridge Antibody Technology Group plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cambridge Antibody Technology Group plc Companies in our database. You can also find out about relevant Cambridge Antibody Technology Group plc Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record